Forty‐nine patients were positive for DNMT3A, of which 31 were AITL, 12 were PTCL‐NOS, 5 were ENKTL, and 1 was ALK‐ALCL. This evidence concerns the gene ALK and angioimmunoblastic T-cell lymphoma.